Kenji Kadomatsu

15.7k total citations · 1 hit paper
286 papers, 12.6k citations indexed

About

Kenji Kadomatsu is a scholar working on Molecular Biology, Cell Biology and Immunology. According to data from OpenAlex, Kenji Kadomatsu has authored 286 papers receiving a total of 12.6k indexed citations (citations by other indexed papers that have themselves been cited), including 176 papers in Molecular Biology, 128 papers in Cell Biology and 44 papers in Immunology. Recurrent topics in Kenji Kadomatsu's work include Proteoglycans and glycosaminoglycans research (119 papers), Glycosylation and Glycoproteins Research (64 papers) and Fibroblast Growth Factor Research (37 papers). Kenji Kadomatsu is often cited by papers focused on Proteoglycans and glycosaminoglycans research (119 papers), Glycosylation and Glycoproteins Research (64 papers) and Fibroblast Growth Factor Research (37 papers). Kenji Kadomatsu collaborates with scholars based in Japan, United States and Russia. Kenji Kadomatsu's co-authors include Takashi Muramatsu, Takashi Muramatsu, Mineko Tomomura, Kazuma Sakamoto, Seiichi Matsuo, Yoshifumi Takei, Kenji Uchimura, Yukio Yuzawa, Naoki Ishiguro and Shiro Imagama and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Circulation.

In The Last Decade

Kenji Kadomatsu

282 papers receiving 12.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Minocycline selectively inhibits M1 polarization of microglia

2013 594 citations Kenji Uchimura, Kazuma Sakamoto et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Kenji Kadomatsu Japan	61	7.4k	4.9k	1.8k	1.7k	1.6k	286	12.6k
William B. Stallcup United States	63	6.8k 0.9×	2.7k 0.6×	1.3k 0.7×	1.8k 1.1×	1.4k 0.9×	146	13.0k
Andrius Kazlauskas United States	60	9.8k 1.3×	2.2k 0.5×	2.3k 1.3×	1.3k 0.8×	2.4k 1.5×	188	15.1k
Thomas F. Deuel United States	61	8.1k 1.1×	3.1k 0.6×	1.7k 0.9×	1.7k 1.0×	2.2k 1.4×	170	15.8k
Yu Yamaguchi Japan	60	8.1k 1.1×	6.5k 1.3×	1.1k 0.6×	1.2k 0.7×	1.1k 0.7×	226	15.7k
Shigeki Higashiyama Japan	64	8.2k 1.1×	2.6k 0.5×	2.1k 1.1×	2.0k 1.2×	4.4k 2.9×	279	15.6k
Helmut Ponta Germany	54	8.9k 1.2×	5.3k 1.1×	2.1k 1.1×	1.8k 1.1×	3.3k 2.1×	142	14.7k
Takahiro Kunisada Japan	49	7.1k 1.0×	2.1k 0.4×	2.4k 1.3×	1.4k 0.8×	2.5k 1.6×	209	12.6k
Anne Eichmann France	65	8.8k 1.2×	2.8k 0.6×	912 0.5×	1.4k 0.8×	2.8k 1.8×	147	13.8k
Jack Lawler United States	77	11.8k 1.6×	2.6k 0.5×	2.3k 1.3×	4.7k 2.8×	2.9k 1.9×	206	20.2k
Joanne E. Murphy-Ullrich United States	56	5.8k 0.8×	2.0k 0.4×	2.2k 1.2×	1.8k 1.1×	1.4k 0.9×	111	11.3k

Countries citing papers authored by Kenji Kadomatsu

Since Specialization

Citations

This map shows the geographic impact of Kenji Kadomatsu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kenji Kadomatsu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kenji Kadomatsu more than expected).

Fields of papers citing papers by Kenji Kadomatsu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kenji Kadomatsu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kenji Kadomatsu. The network helps show where Kenji Kadomatsu may publish in the future.

Co-authorship network of co-authors of Kenji Kadomatsu

This figure shows the co-authorship network connecting the top 25 collaborators of Kenji Kadomatsu. A scholar is included among the top collaborators of Kenji Kadomatsu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kenji Kadomatsu. Kenji Kadomatsu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Kato, Noritoshi, Fuminori Sato, Shoma Tsubota, et al.. (2025). Ameliorative Effect of an Anti–MicroRNA-21 Oligonucleotide on Animal and Human Models of Cystic Kidney Disease. Kidney360. 6(6). 900–913.

Maeda, Kayaho, Noritoshi Kato, Yuka Sato, et al.. (2023). Basigin is released in extracellular vesicles derived from the renal tubular epithelium in response to albuminuria. Nephrology. 28(11). 629–638.

Nadanaka, Satomi, et al.. (2021). Chondroitin 6-sulfate represses keratinocyte proliferation in mouse skin, which is associated with psoriasis. Communications Biology. 4(1). 114–114. 15 indexed citations

Okubo, Aoi, Youhei Uchida, Yuko Higashi, et al.. (2021). CD147 Is Essential for the Development of Psoriasis via the Induction of Th17 Cell Differentiation. International Journal of Molecular Sciences. 23(1). 177–177. 12 indexed citations

Takeda‐Uchimura, Yoshiko, Tahmina Foyez, Zui Zhang, et al.. (2019). GlcNAc6ST3 is a keratan sulfate sulfotransferase for the protein-tyrosine phosphatase PTPRZ in the adult brain. Scientific Reports. 9(1). 4387–4387. 20 indexed citations

Funahashi, Y., Noritoshi Kato, Tomohiro Masuda, et al.. (2019). miR-146a targeted to splenic macrophages prevents sepsis-induced multiple organ injury. Laboratory Investigation. 99(8). 1130–1142. 39 indexed citations

Tsubota, Shoma, Satoshi Kishida, Teppei Shimamura, et al.. (2017). PRC2-Mediated Transcriptomic Alterations at the Embryonic Stage Govern Tumorigenesis and Clinical Outcome in MYCN-Driven Neuroblastoma. Cancer Research. 77(19). 5259–5271. 25 indexed citations

Murakami‐Tonami, Yuko, Haruna Ikeda, Ryota Yamagishi, et al.. (2016). SGO1 is involved in the DNA damage response in MYCN-amplified neuroblastoma cells. Scientific Reports. 6(1). 31615–31615. 13 indexed citations

Kiyonari, Shinichi, Makoto Iimori, Kazuaki Matsuoka, et al.. (2015). The 1,2-Diaminocyclohexane Carrier Ligand in Oxaliplatin Induces p53-Dependent Transcriptional Repression of Factors Involved in Thymidylate Biosynthesis. Molecular Cancer Therapeutics. 14(10). 2332–2342. 26 indexed citations

10.

Kishida, Satoshi, Ping Mu, Shin Miyakawa, et al.. (2012). Midkine Promotes Neuroblastoma through Notch2 Signaling. Cancer Research. 73(4). 1318–1327. 50 indexed citations

11.

Kojima, Hiroshi, Tomoki Kosugi, Waichi Sato, et al.. (2012). Deficiency of Growth Factor Midkine Exacerbates Necrotizing Glomerular Injuries in Progressive Glomerulonephritis. American Journal Of Pathology. 182(2). 410–419. 9 indexed citations

12.

Sakamoto, Kazuma & Kenji Kadomatsu. (2011). Keratan Sulfate in Neuronal Network Reconstruction. Trends in Glycoscience and Glycotechnology. 23(133). 212–220. 7 indexed citations

13.

Huet, E., Benoît Vallée, Jean Delbé, et al.. (2011). EMMPRIN Modulates Epithelial Barrier Function through a MMP–Mediated Occludin Cleavage. American Journal Of Pathology. 179(3). 1278–1286. 51 indexed citations

14.

Huang, Peng, Satoshi Kishida, Dongliang Cao, et al.. (2011). The Neuronal Differentiation Factor NeuroD1 Downregulates the Neuronal Repellent Factor Slit2 Expression and Promotes Cell Motility and Tumor Formation of Neuroblastoma. Cancer Research. 71(8). 2938–2948. 51 indexed citations

15.

Takei, Yoshifumi, Ping Mu, Tatsuya Fujishima, et al.. (2008). In vivo silencing of a molecular target by short interfering RNA electroporation: tumor vascularization correlates to delivery efficiency. Molecular Cancer Therapeutics. 7(1). 211–221. 31 indexed citations

16.

Horiba, Mitsuru, Hisaaki Ishiguro, Arihiro Sumida, et al.. (2008). Midkine prevents ventricular remodeling and improves long-term survival after myocardial infarction. American Journal of Physiology-Heart and Circulatory Physiology. 296(2). H462–H469. 46 indexed citations

17.

Shibata, Yoshihisa, Takashi Muramatsu, Makoto Hirai, et al.. (2002). Nuclear Targeting by the Growth Factor Midkine. Molecular and Cellular Biology. 22(19). 6788–6796. 117 indexed citations

18.

Sato, Waichi, Kenji Kadomatsu, Yukio Yuzawa, et al.. (2001). Midkine Is Involved in Neutrophil Infiltration into the Tubulointerstitium in Ischemic Renal Injury. The Journal of Immunology. 167(6). 3463–3469. 157 indexed citations

19.

Aridome, Kuniaki, Sonshin Takao, Tadashi Kaname, et al.. (1998). Truncated midkine as a marker of diagnosis and detection of nodal metastases in gastrointestinal carcinomas. British Journal of Cancer. 78(4). 472–477. 37 indexed citations

20.

Mishima, Kazuhiko, Akio Asai, Kenji Kadomatsu, et al.. (1997). Increased expression of midkine during the progression of human astrocytomas. Neuroscience Letters. 233(1). 29–32. 93 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact